Products and services

Novo Nordisk is a world leader in diabetes care with the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems.

In addition, we have a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. We develop, manufacture and market pharmaceutical products and services that make a significant difference to patients, the medical profession and society.

We offer products and services in the following therapy areas:

Diabetes care

Haemostasis management (NovoSeven®)

Growth hormone therapy

Hormone replacement therapy (HRT)

  •  

Stock exchange announcement

Full year results 2004
  •  
  •  

Case stories

Results with stakeholders
  •  
  •  
Annual Report 2004
  •